Clinical Trial Update: Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain [Phase 2]

View source ↗

Summary

Phase 2 dose-response study of MR-107A-01 for post-surgical dental pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• MR-107A-01

Snippet

Sponsor: Mylan Inc. | Conditions: Pain, Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-08-08